Abstract
ABSTRACTA major problem in HIV/AIDS studies is the development of drug resistance to antiretroviral (ARV) drug or therapy. Estimating the time at which such drug resistance would develop is usually sought. The goal of this article is to perform this estimation by developing growth mixture models with change-points and skew-t distributions based on longitudinal data. For such data, following ARV treatment, the profile of each subject’s viral load tends to follow a ‘broken stick’ like growth trajectory, indicating multiple phases of decline and increase in viral loads. These multiple phases with multiple change-points are captured by subject-specific random parameters of growth curve models. To account for heterogeneity of drug resistance among subjects, the change-points are also allowed to differ by subgroups (subpopulations) of patients classified into latent classes on the basis of trajectories of observed viral loads. The proposed methods are illustrated using real data from an AIDS clinical study.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
